当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第21期
编号:185740
常规降糖基础上联合达格列净片对青年T2DM并发肝病患者肝功能与血管内皮功能的影响
http://www.100md.com 2021年3月27日 中国医学创新 2021年第21期
     邓晓君

    【关键词】 达格列净片 2型糖尿病 肝病 肝功能 血管内皮功能

    [Abstract] Objective: To observe the effect of Dapagliflozin Tablets combined with routine hypoglycemic on liver function and vascular endothelial function in young patients with type 2 diabetes mellitus (T2DM) complicated with liver disease. Method: A total of 108 young T2DM patients with liver disease admitted to our hospital from January to June 2020 were selected as the research objects. The patients were divided into routine hypoglycemic group and combined hypoglycemic group by envelope random number method, 54 patients in each group. The routine hypoglycemic group was given Metformin to control blood glucose, and the combined hypoglycemic group was given Dapagliflozin Tablets to control blood glucose on the basis of the routine hypoglycemic group ......

您现在查看是摘要页,全文长 13170 字符